NCT02601989View on ClinicalTrials.gov

Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Tadalafil

DRUG

Placebo

Per oral intake of placebo for six weeks

Trial Locations (1)

41345

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Vastra Gotaland Region

OTHER_GOV

lead

Göteborg University

OTHER

NCT02601989 - Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study | Biotech Hunter | Biotech Hunter